Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Indivior ( (INDV) ).
Barclays PLC has increased its voting rights in Indivior PLC, crossing a significant threshold on July 16, 2025. This change in holdings, which was notified on July 18, 2025, reflects Barclays’ strategic investment position in Indivior, potentially impacting the company’s governance and market perception.
More about Indivior
Indivior PLC is a UK-based pharmaceutical company that specializes in the development and distribution of medications for the treatment of addiction and related mental health disorders. The company focuses on providing innovative solutions to address the global addiction crisis.
Learn more about INDV stock on TipRanks’ Stock Analysis page.